APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oral TYK2 Inhibitors

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral TYK2 Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025188 pages

Choose your research edition.

Industry ResearchOral TYK2 Inhibitors Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral TYK2 Inhibitors Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Oral TYK2 Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral TYK2 Inhibitors Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral TYK2 Inhibitors Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oral TYK2 Inhibitors market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oral TYK2 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral TYK2 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral TYK2 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral TYK2 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral TYK2 Inhibitors include Bristol Myers Squibb, Galapagos NV, Takeda (Nimbus Therapeutics), Ventyx Biosciences, Changzhou Hengbang Pharmaceutical, Highlightll Pharma, InnoCare and Inventisbio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral TYK2 Inhibitors market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral TYK2 Inhibitors and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral TYK2 Inhibitors sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral TYK2 Inhibitors market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral TYK2 Inhibitors Segment by Company

Bristol Myers Squibb

Galapagos NV

Takeda (Nimbus Therapeutics)

Ventyx Biosciences

Changzhou Hengbang Pharmaceutical

Highlightll Pharma

InnoCare

Inventisbio

Oral TYK2 Inhibitors Segment by Type

Single-target Inhibitors

Dual-target Inhibitors

Oral TYK2 Inhibitors Segment by Application

Psoriasis

Systemic Lupus Erythematosus

Dermatitis

Arthritis

Others

Oral TYK2 Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral TYK2 Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral TYK2 Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral TYK2 Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral TYK2 Inhibitors market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral TYK2 Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oral TYK2 Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oral TYK2 Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oral TYK2 Inhibitors Industry Trends Table 2. Oral TYK2 Inhibitors Industry Drivers Table 3. Oral TYK2 Inhibitors Industry Opportunities and Challenges Table 4. Oral TYK2 Inhibitors Industry Restraints Table 5. Global Oral TYK2 Inhibitors Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oral TYK2 Inhibitors Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oral TYK2 Inhibitors Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Oral TYK2 Inhibitors Sales Market Share by Manufacturers Table 9. Global Oral TYK2 Inhibitors Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Oral TYK2 Inhibitors Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oral TYK2 Inhibitors Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oral TYK2 Inhibitors Manufacturers, Product Type & Application Table 13. Global Oral TYK2 Inhibitors Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral TYK2 Inhibitors by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Single-target Inhibitors Table 17. Major Manufacturers of Dual-target Inhibitors Table 18. Global Oral TYK2 Inhibitors Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units) Table 20. Global Oral TYK2 Inhibitors Sales by Type (2027-2032) & (K Units) Table 21. Global Oral TYK2 Inhibitors Sales Market Share by Type (2021-2026) Table 22. Global Oral TYK2 Inhibitors Sales Market Share by Type (2027-2032) Table 23. Global Oral TYK2 Inhibitors Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Oral TYK2 Inhibitors Revenue by Type (2021-2026) & (K Units) Table 25. Global Oral TYK2 Inhibitors Revenue by Type (2027-2032) & (K Units) Table 26. Global Oral TYK2 Inhibitors Revenue Market Share by Type (2021-2026) Table 27. Global Oral TYK2 Inhibitors Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Psoriasis Table 29. Major Manufacturers of Systemic Lupus Erythematosus Table 30. Major Manufacturers of Dermatitis Table 31. Major Manufacturers of Arthritis Table 32. Major Manufacturers of Others Table 33. Global Oral TYK2 Inhibitors Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units) Table 35. Global Oral TYK2 Inhibitors Sales by Application (2027-2032) & (K Units) Table 36. Global Oral TYK2 Inhibitors Sales Market Share by Application (2021-2026) Table 37. Global Oral TYK2 Inhibitors Sales Market Share by Application (2027-2032) Table 38. Global Oral TYK2 Inhibitors Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Oral TYK2 Inhibitors Revenue by Application (2021-2026) & (K Units) Table 40. Global Oral TYK2 Inhibitors Revenue by Application (2027-2032) & (K Units) Table 41. Global Oral TYK2 Inhibitors Revenue Market Share by Application (2021-2026) Table 42. Global Oral TYK2 Inhibitors Revenue Market Share by Application (2027-2032) Table 43. Global Oral TYK2 Inhibitors Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Oral TYK2 Inhibitors Sales by Region (2021-2026) & (K Units) Table 45. Global Oral TYK2 Inhibitors Sales Market Share by Region (2021-2026) Table 46. Global Oral TYK2 Inhibitors Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Oral TYK2 Inhibitors Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Oral TYK2 Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units) Table 50. North America Oral TYK2 Inhibitors Sales by Country (2027-2032) & (K Units) Table 51. Europe Oral TYK2 Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units) Table 53. Europe Oral TYK2 Inhibitors Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Oral TYK2 Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Oral TYK2 Inhibitors Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Oral TYK2 Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Oral TYK2 Inhibitors Sales by Country (2027-2032) & (K Units) Table 60. Global Oral TYK2 Inhibitors Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Oral TYK2 Inhibitors Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Oral TYK2 Inhibitors Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Oral TYK2 Inhibitors Revenue Market Share by Region (2021-2026) Table 64. Global Oral TYK2 Inhibitors Revenue Market Share by Region (2027-2032) Table 65. Bristol Myers Squibb Company Information Table 66. Bristol Myers Squibb Business Overview Table 67. Bristol Myers Squibb Oral TYK2 Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Bristol Myers Squibb Oral TYK2 Inhibitors Product Portfolio Table 69. Bristol Myers Squibb Recent Development Table 70. Galapagos NV Company Information Table 71. Galapagos NV Business Overview Table 72. Galapagos NV Oral TYK2 Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Galapagos NV Oral TYK2 Inhibitors Product Portfolio Table 74. Galapagos NV Recent Development Table 75. Takeda (Nimbus Therapeutics) Company Information Table 76. Takeda (Nimbus Therapeutics) Business Overview Table 77. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Product Portfolio Table 79. Takeda (Nimbus Therapeutics) Recent Development Table 80. Ventyx Biosciences Company Information Table 81. Ventyx Biosciences Business Overview Table 82. Ventyx Biosciences Oral TYK2 Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Ventyx Biosciences Oral TYK2 Inhibitors Product Portfolio Table 84. Ventyx Biosciences Recent Development Table 85. Changzhou Hengbang Pharmaceutical Company Information Table 86. Changzhou Hengbang Pharmaceutical Business Overview Table 87. Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Product Portfolio Table 89. Changzhou Hengbang Pharmaceutical Recent Development Table 90. Highlightll Pharma Company Information Table 91. Highlightll Pharma Business Overview Table 92. Highlightll Pharma Oral TYK2 Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Highlightll Pharma Oral TYK2 Inhibitors Product Portfolio Table 94. Highlightll Pharma Recent Development Table 95. InnoCare Company Information Table 96. InnoCare Business Overview Table 97. InnoCare Oral TYK2 Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. InnoCare Oral TYK2 Inhibitors Product Portfolio Table 99. InnoCare Recent Development Table 100. Inventisbio Company Information Table 101. Inventisbio Business Overview Table 102. Inventisbio Oral TYK2 Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Inventisbio Oral TYK2 Inhibitors Product Portfolio Table 104. Inventisbio Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Oral TYK2 Inhibitors Distributors List Table 108. Oral TYK2 Inhibitors Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Oral TYK2 Inhibitors Product Image Figure 2. Global Oral TYK2 Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral TYK2 Inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral TYK2 Inhibitors Sales (2021-2032) & (K Units) Figure 5. Global Oral TYK2 Inhibitors Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oral TYK2 Inhibitors Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Single-target Inhibitors Image Figure 9. Dual-target Inhibitors Image Figure 10. Global Oral TYK2 Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Oral TYK2 Inhibitors Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Oral TYK2 Inhibitors Sales Market Share by Type (2021-2032) Figure 13. Global Oral TYK2 Inhibitors Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Oral TYK2 Inhibitors Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Oral TYK2 Inhibitors Revenue Market Share by Type (2021-2032) Figure 16. Psoriasis Image Figure 17. Systemic Lupus Erythematosus Image Figure 18. Dermatitis Image Figure 19. Arthritis Image Figure 20. Others Image Figure 21. Global Oral TYK2 Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Oral TYK2 Inhibitors Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Oral TYK2 Inhibitors Sales Market Share by Application (2021-2032) Figure 24. Global Oral TYK2 Inhibitors Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Oral TYK2 Inhibitors Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Oral TYK2 Inhibitors Revenue Market Share by Application (2021-2032) Figure 27. North America Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Oral TYK2 Inhibitors Sales Market Share by Country (2021-2032) Figure 29. U.S. Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Oral TYK2 Inhibitors Sales Market Share by Country (2021-2032) Figure 34. Germany Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Oral TYK2 Inhibitors Sales Market Share by Country (2021-2032) Figure 41. China Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Oral TYK2 Inhibitors Sales Market Share by Country (2021-2032) Figure 49. Brazil Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Oral TYK2 Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Oral TYK2 Inhibitors Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Oral TYK2 Inhibitors Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Oral TYK2 Inhibitors Revenue (2021-2032) & (US$ Million) Figure 60. North America Oral TYK2 Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Oral TYK2 Inhibitors Revenue (2021-2032) & (US$ Million) Figure 62. Europe Oral TYK2 Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Oral TYK2 Inhibitors Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Oral TYK2 Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Oral TYK2 Inhibitors Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Oral TYK2 Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Oral TYK2 Inhibitors Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Oral TYK2 Inhibitors Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Single-target Inhibitors
  • Dual-target Inhibitors
Applications
  • Psoriasis
  • Systemic Lupus Erythematosus
  • Dermatitis
  • Arthritis
  • Others
Companies covered
  • Bristol Myers Squibb
  • Galapagos NV
  • Takeda (Nimbus Therapeutics)
  • Ventyx Biosciences
  • Changzhou Hengbang Pharmaceutical
  • Highlightll Pharma
  • InnoCare
  • Inventisbio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oral TYK2 Inhibitors Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oral TYK2 Inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oral TYK2 Inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oral TYK2 Inhibitors Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oral TYK2 Inhibitors Market Dynamics
  1. 2.1 Oral TYK2 Inhibitors Industry Trends
  2. 2.2 Oral TYK2 Inhibitors Industry Drivers
  3. 2.3 Oral TYK2 Inhibitors Industry Opportunities and Challenges
  4. 2.4 Oral TYK2 Inhibitors Industry Restraints
3 Oral TYK2 Inhibitors Market by Manufacturers
  1. 3.1 Global Oral TYK2 Inhibitors Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oral TYK2 Inhibitors Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oral TYK2 Inhibitors Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oral TYK2 Inhibitors Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral TYK2 Inhibitors Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oral TYK2 Inhibitors Manufacturers, Product Type & Application
  7. 3.7 Global Oral TYK2 Inhibitors Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral TYK2 Inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral TYK2 Inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral TYK2 Inhibitors Tier 1, Tier 2, and Tier 3
4 Oral TYK2 Inhibitors Market by Type
  1. 4.1 Oral TYK2 Inhibitors Type Introduction
  2. 4.1.1 Single-target Inhibitors
  3. 4.1.2 Dual-target Inhibitors
  4. 4.2 Global Oral TYK2 Inhibitors Sales by Type
  5. 4.2.1 Global Oral TYK2 Inhibitors Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oral TYK2 Inhibitors Sales by Type (2021-2032)
  7. 4.2.3 Global Oral TYK2 Inhibitors Sales Market Share by Type (2021-2032)
  8. 4.3 Global Oral TYK2 Inhibitors Revenue by Type
  9. 4.3.1 Global Oral TYK2 Inhibitors Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Oral TYK2 Inhibitors Revenue by Type (2021-2032)
  11. 4.3.3 Global Oral TYK2 Inhibitors Revenue Market Share by Type (2021-2032)
5 Oral TYK2 Inhibitors Market by Application
  1. 5.1 Oral TYK2 Inhibitors Application Introduction
  2. 5.1.1 Psoriasis
  3. 5.1.2 Systemic Lupus Erythematosus
  4. 5.1.3 Dermatitis
  5. 5.1.4 Arthritis
  6. 5.1.5 Others
  7. 5.2 Global Oral TYK2 Inhibitors Sales by Application
  8. 5.2.1 Global Oral TYK2 Inhibitors Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Oral TYK2 Inhibitors Sales by Application (2021-2032)
  10. 5.2.3 Global Oral TYK2 Inhibitors Sales Market Share by Application (2021-2032)
  11. 5.3 Global Oral TYK2 Inhibitors Revenue by Application
  12. 5.3.1 Global Oral TYK2 Inhibitors Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Oral TYK2 Inhibitors Revenue by Application (2021-2032)
  14. 5.3.3 Global Oral TYK2 Inhibitors Revenue Market Share by Application (2021-2032)
6 Global Oral TYK2 Inhibitors Sales by Region
  1. 6.1 Global Oral TYK2 Inhibitors Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral TYK2 Inhibitors Sales by Region (2021-2032)
  3. 6.2.1 Global Oral TYK2 Inhibitors Sales by Region (2021-2026)
  4. 6.2.2 Global Oral TYK2 Inhibitors Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oral TYK2 Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oral TYK2 Inhibitors Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oral TYK2 Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oral TYK2 Inhibitors Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oral TYK2 Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oral TYK2 Inhibitors Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oral TYK2 Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oral TYK2 Inhibitors Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oral TYK2 Inhibitors Revenue by Region
  1. 7.1 Global Oral TYK2 Inhibitors Revenue by Region
  2. 7.1.1 Global Oral TYK2 Inhibitors Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oral TYK2 Inhibitors Revenue by Region (2021-2026)
  4. 7.1.3 Global Oral TYK2 Inhibitors Revenue by Region (2027-2032)
  5. 7.1.4 Global Oral TYK2 Inhibitors Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oral TYK2 Inhibitors Revenue (2021-2032)
  8. 7.2.2 North America Oral TYK2 Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oral TYK2 Inhibitors Revenue (2021-2032)
  11. 7.3.2 Europe Oral TYK2 Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oral TYK2 Inhibitors Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oral TYK2 Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oral TYK2 Inhibitors Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oral TYK2 Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bristol Myers Squibb
  2. 8.1.1 Bristol Myers Squibb Company Information
  3. 8.1.2 Bristol Myers Squibb Business Overview
  4. 8.1.3 Bristol Myers Squibb Oral TYK2 Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bristol Myers Squibb Oral TYK2 Inhibitors Product Portfolio
  6. 8.1.5 Bristol Myers Squibb Recent Developments
  7. 8.2 Galapagos NV
  8. 8.2.1 Galapagos NV Company Information
  9. 8.2.2 Galapagos NV Business Overview
  10. 8.2.3 Galapagos NV Oral TYK2 Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Galapagos NV Oral TYK2 Inhibitors Product Portfolio
  12. 8.2.5 Galapagos NV Recent Developments
  13. 8.3 Takeda (Nimbus Therapeutics)
  14. 8.3.1 Takeda (Nimbus Therapeutics) Company Information
  15. 8.3.2 Takeda (Nimbus Therapeutics) Business Overview
  16. 8.3.3 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Product Portfolio
  18. 8.3.5 Takeda (Nimbus Therapeutics) Recent Developments
  19. 8.4 Ventyx Biosciences
  20. 8.4.1 Ventyx Biosciences Company Information
  21. 8.4.2 Ventyx Biosciences Business Overview
  22. 8.4.3 Ventyx Biosciences Oral TYK2 Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ventyx Biosciences Oral TYK2 Inhibitors Product Portfolio
  24. 8.4.5 Ventyx Biosciences Recent Developments
  25. 8.5 Changzhou Hengbang Pharmaceutical
  26. 8.5.1 Changzhou Hengbang Pharmaceutical Company Information
  27. 8.5.2 Changzhou Hengbang Pharmaceutical Business Overview
  28. 8.5.3 Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Product Portfolio
  30. 8.5.5 Changzhou Hengbang Pharmaceutical Recent Developments
  31. 8.6 Highlightll Pharma
  32. 8.6.1 Highlightll Pharma Company Information
  33. 8.6.2 Highlightll Pharma Business Overview
  34. 8.6.3 Highlightll Pharma Oral TYK2 Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Highlightll Pharma Oral TYK2 Inhibitors Product Portfolio
  36. 8.6.5 Highlightll Pharma Recent Developments
  37. 8.7 InnoCare
  38. 8.7.1 InnoCare Company Information
  39. 8.7.2 InnoCare Business Overview
  40. 8.7.3 InnoCare Oral TYK2 Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 InnoCare Oral TYK2 Inhibitors Product Portfolio
  42. 8.7.5 InnoCare Recent Developments
  43. 8.8 Inventisbio
  44. 8.8.1 Inventisbio Company Information
  45. 8.8.2 Inventisbio Business Overview
  46. 8.8.3 Inventisbio Oral TYK2 Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Inventisbio Oral TYK2 Inhibitors Product Portfolio
  48. 8.8.5 Inventisbio Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral TYK2 Inhibitors Value Chain Analysis
  2. 9.1.1 Oral TYK2 Inhibitors Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral TYK2 Inhibitors Production Mode & Process
  6. 9.2 Oral TYK2 Inhibitors Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral TYK2 Inhibitors Distributors
  9. 9.2.3 Oral TYK2 Inhibitors Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst